Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

Filter by All Topics
Trainee & Early-Career Oncology
Virginia D. Anderson
May 25, 2016 2:22 PM
As we continue to make improvements to ASCOconnection.org, we want to make the Discussion section meaningful for medical students, interns, residents, fellows, and young professionals in oncology. We welcome your feedback!
What kinds of questions would you like to ask your oncology community about...
Molecular Oncology Tumor Board
ASCO University
May 11, 2016 9:46 AM
Read more to answer the following questions: 1) Would further imaging be required before discussing a plan for systemic therapy?  2) Which of the available tissue specimen/sites would be appropriate for HER2 testing: tissue from the primary resection specimen, metastasis from the para-aortic lymph...
ASCO International Affairs
May 09, 2016 11:24 AM
ASCO partnered with local organizers to hold two Cancer Control in Primary Care (CCPC) courses in November 2015 and February 2016. The evaluation results for both courses indicate that the majority of respondents intend to make practice changes and gained new knowledge and skills as a result of...
Mark R. Hutchins, MD
Apr 26, 2016 10:50 PM
Has there ever been a PRCT of AC/T vs "other" in a pure TNBC stratified group (in the NeoAdj setting or the Adj setting?) showing that AC/T vs "other" showed a superior survival? When we say that AC/T shows a survival advantage, advantage over what?
The origninal AC vs CMF showed little if any...
Molecular Oncology Tumor Board
ASCO University
Apr 13, 2016 9:33 AM
Read more to answer the following questions: 1) What are available second line therapy options? 2)  Do you test for PD-L1 prior to recommending therapy? 3) Does smoking history affect your treatment recommendations?